In this podcast, Leslie R. Schover, PhD, discusses the sexual concerns that often come with hormone therapy for prostate cancer.
Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
Study Shows a Certain Type of Baldness at Age 45 May Increase the Risk for Aggressive Prostate Cancer
Men who have lost their hair at the front and top of their heads at age 45 have a 40% increased risk of developing faster-growing prostate cancer later in life.
Anne Katz, RN, PhD, discusses how she helps men and their partners better understand prostate cancer treatment decisions, especially its potential long-term effects on masculinity, self-image, and quality of life.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.
Get highlights of five studies showing promise in novel targeted therapies, cancer prevention, and patient care that will be presented at ASCO’s 50th Annual Meeting.
Learn about the latest advances in the treatment of prostate and kidney cancers, as well as information on why clinical trials end early.